Published in Front Cardiovasc Med on September 12, 2016
Inflammation in atherosclerosis. Nature (2002) 28.92
Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA (2010) 13.94
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 12.79
A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis (1967) 7.51
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med (1998) 4.51
Acculturation and coronary heart disease in Japanese-Americans. Am J Epidemiol (1976) 4.18
Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood. N Engl J Med (2016) 3.64
Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A (2010) 3.51
Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol (1975) 3.26
Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med (2014) 3.24
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J (2008) 2.97
Coronary artery disease in combat casualties in Vietnam. JAMA (1971) 2.72
The epidemiology of coronary heart disease--the Framingham enquiry. Proc R Soc Med (1962) 2.55
Pathogenesis of coronary disease in American soldiers killed in Korea. J Am Med Assoc (1955) 2.43
Virus-induced atherosclerosis. J Exp Med (1978) 2.32
Human papillomavirus and cardiovascular disease among U.S. women in the National Health and Nutrition Examination Survey, 2003 to 2006. J Am Coll Cardiol (2011) 2.13
Coronary heart disease epidemics: not all the same. Heart (2008) 2.07
Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol Metab (2009) 2.05
Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev (2015) 1.94
Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol (2014) 1.75
Recent trends in the prevalence of coronary disease: a population-based autopsy study of nonnatural deaths. Arch Intern Med (2008) 1.69
Prevalence of and risk factors for autopsy-determined atherosclerosis among US service members, 2001-2011. JAMA (2012) 1.69
Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr (2015) 1.65
Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol (2006) 1.53
Blood pressure and risk of coronary heart disease: the Framingham study. Dis Chest (1969) 1.52
Insights into the role of infection in atherogenesis and in plaque rupture. Circulation (2009) 1.39
Inflammation and infection do not promote arterial aging and cardiovascular disease risk factors among lean horticulturalists. PLoS One (2009) 1.38
IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. J Immunol (2010) 1.36
Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia. Am J Hum Biol (2010) 1.30
Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol (2005) 1.26
Differences in cardiovascular disease risk factors between Japanese in Japan and Japanese-Americans in Hawaii: the INTERLIPID study. J Hum Hypertens (2003) 1.17
Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol (2005) 1.14
Effect of chronic Pseudomonas aeruginosa infection on the development of atherosclerosis in a rat model. Clin Microbiol Infect (2004) 1.13
Role of the normal gut microbiota. World J Gastroenterol (2015) 1.12
Lipid metabolism in patients infected with Nef-deficient HIV-1 strain. Atherosclerosis (2015) 1.10
The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing. Discov Med (2012) 1.08
Herpesvirus infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells. Am J Pathol (1981) 1.08
Lipid and macrophage accumulations in arteries of children and the development of atherosclerosis. Am J Clin Nutr (2000) 1.04
Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One (2011) 1.04
Time trends in the prevalence of atherosclerosis: a population-based autopsy study. Am J Med (2001) 1.04
Global trend in overweight and obesity and its association with cardiovascular disease incidence. Circ J (2014) 1.02
Human cytomegalovirus infection and atherothrombosis. J Thromb Thrombolysis (2012) 1.01
Infection and Atherosclerosis Development. Arch Med Res (2015) 0.96
Doxycycline affects diet- and bacteria-associated atherosclerosis in an ApoE heterozygote murine model: cytokine profiling implications. Atherosclerosis (2006) 0.94
Human cytomegalovirus regulates bioactive sphingolipids. J Biol Chem (2008) 0.93
Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques. Am J Pathol (2009) 0.93
Generation and characterization of human smooth muscle cell lines derived from atherosclerotic plaque. Arterioscler Thromb Vasc Biol (1999) 0.93
Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens. Am Heart J (1999) 0.93
The UPS and downs of cholesterol homeostasis. Trends Biochem Sci (2014) 0.91
Alteration of lipid metabolism in cells infected with human cytomegalovirus. Virology (2010) 0.90
Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences. Curr Cardiol Rep (2014) 0.88
Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis. J Oral Microbiol (2014) 0.87
Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest (1996) 0.87
A changing view on saturated fatty acids and dairy: from enemy to friend. Am J Clin Nutr (2014) 0.87
Study of fibrous plaques occurring in the coronary arteries of children. Atherosclerosis (1979) 0.86
Evidence for a vascular microbiome and its role in vessel health and disease. Curr Opin Rheumatol (2015) 0.85
Detection of infectious agents by polymerase chain reaction in human aortic wall. Cardiovasc Pathol (2008) 0.84
Detection of enterovirus, cytomegalovirus, and Chlamydia pneumoniae in atheromas. J Microbiol (2004) 0.84
In silico analyses of metagenomes from human atherosclerotic plaque samples. Microbiome (2015) 0.83
Perinatal and infant early atherosclerotic coronary lesions. Can J Cardiol (2008) 0.82
Identification of Human Papilloma Viruses in Atheromatous Coronary Artery Disease. Front Cardiovasc Med (2015) 0.82
Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages. Oncol Rep (2013) 0.82
With a Little Help from my Enteric Microbial Friends. Front Med (Lausanne) (2015) 0.81
CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease. Dig Dis Sci (2010) 0.81
Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes. Atherosclerosis (2010) 0.81
Association between Chlamydophila pneumoniae infection and risk of coronary heart disease for Japanese: the JPHC study. Atherosclerosis (2014) 0.81
Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection. Endocrinol Metab Clin North Am (2014) 0.81
Cytosolic lipid inclusions formed during infection by viral and bacterial pathogens. Microbes Infect (2012) 0.80
Altered cholesterol trafficking in herpesvirus-infected arterial cells. Evidence for viral protein kinase-mediated cholesterol accumulation. J Biol Chem (1995) 0.80
Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound. BMC Cardiovasc Disord (2014) 0.79
A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice. Cell Immunol (2015) 0.79
Infection-Related Hospitalization in Childhood and Adult Metabolic Outcomes. Pediatrics (2015) 0.79
Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque. Virchows Arch (2008) 0.79
Perinatal inflammation: a common factor in the early origins of cardiovascular disease? Clin Sci (Lond) (2015) 0.78
Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice. Atherosclerosis (2015) 0.78
Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes lipid peroxidation, protein oxidation and DNA damage in lymphoblastoid B cell lines. Lipids Health Dis (2011) 0.78
Human cytomegalovirus-encoded miR-US25-1 aggravates the oxidised low density lipoprotein-induced apoptosis of endothelial cells. Biomed Res Int (2014) 0.78
Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class. PLoS One (2015) 0.78
Secular trends in atherosclerotic lesions: comparison of two studies of autopsied men conducted in different time periods. Mod Pathol (1988) 0.78
HPV-induced recurrent laryngeal papillomatosis: fatty acid role-players. Asia Pac J Clin Nutr (2008) 0.77
Trends in Coronary Atherosclerosis: A Tale of Two Population Subgroups. Am J Med (2015) 0.76
Prevalence of eight putative periodontal pathogens in atherosclerotic plaque of coronary artery disease patients and comparing them with noncardiac subjects: A case-control study. Indian J Dent Res (2015) 0.76
Chlamydia Pneumoniae and Immunoinflammatory Reactions in an Unstable Atherosclerotic Plaque in Humans. Bull Exp Biol Med (2015) 0.76
A comparison of postmortem coronary atherosclerosis findings in general aviation pilot fatalities. Aviat Space Environ Med (1987) 0.76
Childhood hospitalisation with infection and cardiovascular disease in early-mid adulthood: a longitudinal population-based study. PLoS One (2015) 0.76
Chlamydia pneumoniae disrupts lipid metabolism in human umbilical vein endothelial cells. Mol Med Rep (2014) 0.76
Identification of Human Papilloma Viruses in Atheromatous Coronary Artery Disease. Front Cardiovasc Med (2015) 0.82